PMID- 35807998 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220716 IS - 2079-4991 (Print) IS - 2079-4991 (Electronic) IS - 2079-4991 (Linking) VI - 12 IP - 13 DP - 2022 Jun 23 TI - Controlled Delivery of an Anti-Inflammatory Toxin to Macrophages by Mutagenesis and Nanoparticle Modification. LID - 10.3390/nano12132161 [doi] LID - 2161 AB - Advances in drug delivery systems (DDSs) have enabled the specific delivery of drugs to target cells. Subtilase cytotoxin (SubAB) produced by certain enterohemorrhagic Escherichia coli strains induces endoplasmic reticulum (ER) stress and suppresses nitric oxide generation in macrophages. We previously reported that modification of SubAB with poly(D,L-lactide-co-glycolic) acid (PLGA) nanoparticles (SubAB-PLGA NPs) increased intracellular uptake of SubAB and had an anti-inflammatory effect on macrophages. However, specific delivery of SubAB to macrophages could not be achieved because its effects on other cell types were not negligible. Therefore, to suppress non-specific SubAB binding, we used low-binding mutant SubAB(S35A) (S35A) in which the 35th serine of the B subunit was mutated to alanine. In a macrophage cell line, PLGA NPs modified with S35A (S35A-PLGA NPs) induced ER stress and had anti-inflammatory effects similar to WT-PLGA NPs. However, in an epithelial cell line, S35A-PLGA NPs induced lower ER stress than WT-PLGA NPs. These results suggest that S35A is selectively delivered to macrophages rather than epithelial cells by modification with PLGA NPs and exerts anti-inflammatory effects. Our findings provide a useful technique for protein delivery to macrophages and encourage medical applications of DDSs for the treatment of inflammatory diseases. FAU - Harada, Ayaka AU - Harada A AD - Faculty of Advanced Science and Technology, Kumamoto University, 2-39-1 Kurokami, Chuo-ku, Kumamoto 860-8555, Japan. FAU - Tsutsuki, Hiroyasu AU - Tsutsuki H AUID- ORCID: 0000-0002-6258-6313 AD - Department of Microbiology, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto 860-8556, Japan. FAU - Zhang, Tianli AU - Zhang T AUID- ORCID: 0000-0002-0543-4006 AD - Department of Microbiology, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto 860-8556, Japan. FAU - Yahiro, Kinnosuke AU - Yahiro K AD - Department of Microbiology and Infection Control Sciences, Kyoto Pharmaceutical University, 5 Misasagi-Nakauchi-cho, Yamashina-ku, Kyoto 607-8414, Japan. FAU - Sawa, Tomohiro AU - Sawa T AD - Department of Microbiology, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto 860-8556, Japan. FAU - Niidome, Takuro AU - Niidome T AUID- ORCID: 0000-0002-8070-8708 AD - Faculty of Advanced Science and Technology, Kumamoto University, 2-39-1 Kurokami, Chuo-ku, Kumamoto 860-8555, Japan. LA - eng GR - 20K08823/Ministry of Education, Culture, Sports, Science and Technology/ GR - 21H02071/Ministry of Education, Culture, Sports, Science and Technology/ GR - JPMJCR18H5/Japan Science and Technology Agency/ GR - 000/Takeda Science Foundation/ PT - Journal Article DEP - 20220623 PL - Switzerland TA - Nanomaterials (Basel) JT - Nanomaterials (Basel, Switzerland) JID - 101610216 PMC - PMC9268525 OTO - NOTNLM OT - PLGA nanoparticles OT - anti-inflammatory OT - controlled drug delivery COIS- The authors declare no conflict of interest. EDAT- 2022/07/10 06:00 MHDA- 2022/07/10 06:01 PMCR- 2022/06/23 CRDT- 2022/07/09 01:22 PHST- 2022/05/19 00:00 [received] PHST- 2022/06/20 00:00 [revised] PHST- 2022/06/20 00:00 [accepted] PHST- 2022/07/09 01:22 [entrez] PHST- 2022/07/10 06:00 [pubmed] PHST- 2022/07/10 06:01 [medline] PHST- 2022/06/23 00:00 [pmc-release] AID - nano12132161 [pii] AID - nanomaterials-12-02161 [pii] AID - 10.3390/nano12132161 [doi] PST - epublish SO - Nanomaterials (Basel). 2022 Jun 23;12(13):2161. doi: 10.3390/nano12132161.